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ABSTRACT
Oulad Abdelati, Howaida. M.S. Department of Microbiology and Immunology, Wright
State University, 2013. Type I Interferon Activation of Natural Killer (NK) Cells by
Cytomegalovirus (CMV) and Their Interaction with Dendritic (DC) and NKT Cells.

In our current study the roles of natural killer (NK) cells in regulation of the acute
phase of murine cytomegalovirus (MCMV) infection were demonstrated. NK cells utilize
perforin and gamma interferon to kill MCMV infected cells. Activation of NK cells is
controlled by the balance between inhibitory and activation receptors and modulated by
cytokines produced from the infected cells. Type I interferons are produced mainly by
plasmacytoid dendritic cells (PDCs). Type I interferons have a substantial role in
enhancing NK cells cytotoxic activity and NK cells proliferation and maintain cell
survival through STAT mediated signaling pathway. IL-12 produced by dendritic cells
activates NK cells and natural killer T (NKT) cells. Natural killer T cells activate NK
cells through IFN-γ production at early time during MCMV infection. These immune
cells and their produced cytokines are critical to regulate MCMV infection and any
disturbance of this activation will lead to impaired host innate immunity.
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I- Introduction
Cytomegalovirus (CMV) is a double stranded DNA virus belonging to the
Betaherpesvirinae sub family. Causing mild to subclinical disease in about 50-90% of the
population, most of patients are asymptomatic and the virus remains in their body in a
latent state. It causes severe to lethal disease in immunocompromised hosts such as AIDs
patients, and patients under immune suppressant drugs. Congenital infections may lead to
fetal disease including deafness and severe neurological defects (Boppana et al., 2001).
Immune surveillance against the CMV virus includes both arms of the immune system,
the innate and the adaptive immunity. This study focuses on the innate immune defense
including cells and effector cytokines.
The first line of the host defense in controlling CMV infection is activation of NK
cells, early production of proinflammatory cytokines, and the activation of the innate
immune cell effector function (Nguyen et al., 2002). Due to the similarity of the human
cytomegalovirus (HCMV) and murine (MCMV) in disease pathogenesis and tissue
tropism (Krmpotic et al., 2003), most of the studies used MCMV as the infective virus to
study the mechanism and the immune regulatory pathway for CMV. Early studies
demonstrated the role of type I interferon and NK cells in early detection and control of
the MCMV replication and spread. During the course of the MCMV infection, biphasic
type I interferon production was described where the IFNα/β was detected as early as six
hours post infection, and the peak level at eight to thirteen hours, and declined by 36 to
1


48 hours post infection. In addition to CMV infected cells, other innate immune cells
respond to CMV by producing type I interferon. These cells are referred to as interferon
producing cells (IPC) and plasmacytoid dendritic cells are the primary population which
release type I interferons in response to the CMV infection (Ito et al., 2006). In addition
to the central role of the type I interferons in direct inhibition of the CMV replication,
they orchestrate other immune cells, such as dendritic cells, macrophages and T cells and
NK cells to mount their antiviral response. There is cooperation among the NK cells,
IPC, and Natural killer T cells (NKT) cells to produce a powerful immune response. IPC
and NKT cells promote the NK cells effector function through IFNα/β enhanced
cytotoxicity and IL-12 inducing IFN-γ production. IFNα/β has a major role in NK cells
activation, proliferation and migration of the cells to the infected compartment.

The hypothesis of this study is that Type-I interferon -producing dendritic cells as
well as IFN- γ producing NKT cells activate the NK cell response against CMV.

Figure 1) Cross-talk between cells of innate immune system during MCMV
infection.
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II- Literature Review- Background
NK cells are bone marrow derived cells which have been described in the early
1970s as a lymphocyte subpopulation, and their cytotoxicity against tumors has been
described (Vivier et al., 2011). Individual NK cells lack unique antigen recognition
receptors and do not use recombination activating gene (RAG) enzymes for
rearrangement of their receptor genes. The innate immune function of NK cells against
different microorganisms has been studied. NK cells have the ability to distinguish self
from non-self-antigens and affect the adaptive immunity through its production of
cytokines and chemokines that affect other immune cells like dendritic cells and
macrophages. The antiviral immune defense basically depends on two types of immunity,
the innate and adaptive immunity NK cells are originally described as the effector cells of
the innate immune response because of their rapid response to the challenge by direct
cytolytic response and cytokine, and chemokine production. However, the adaptive
immunity function of those cells has been recently described.

NK cell development and education
Early studies suggested that the bone marrow is the primary site for NK cell
development and maturation (Huntington, et al., 2007). Although the thymus
environment is critical for NKT cells maturation, NK cells develop independent of the
thymus environment. In the bone marrow, NK cell generation begins with the
development of the natural killer cell precursors (NKP), which express CD122 (B chain
shared between the IL2 and IL 15) from the CD34+ hematopoietic stem cells (HSC).
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NKP further development involve expression of CD161 (a family of C‑type lectin
receptors) cells which is expressed on all immature NK cells. CD161+ CD122+ cells
differentiate to two major subsets, CD56bright CD16- NK cells, which are predominant NK
cell phenotypes in the peripheral tissues, and CD56dim CD16+ cells. CD56brightCD16- cells
are potent IFN-γ producing cells which lack perforin granules and are unable to perform
cytotoxic function. Ninety –five per cent of human blood NK cells are CD56dimCD16+.
They possess perforin granules and have cytotoxic activity. Mouse CD161+ cells are
recognized as NK1.1, further development involves expression of CD49b (DX5) and
Ly49 receptors. Human mature NK cells express CD56, natural cytolytic receptors
(NCR), CD16 (FcγRIII) and KIR. Mature murine NK cells express CD16, Ly49 and
CD49b (DX5) (Figure 2). Dim or bright, indicates the surface density expression of the
cell marker. Bright indicates a strongly positive expression whereas dim indicates
minimal or negative expression of the specific cell surface protein.

Figure 2) Stages of human NK cell development and functional maturation.
Adapted from Freud and Caligiuri 2006.
In addition to a distinct phenotype, NK cells undergo the education phase as a
preparation toward fully responsive cells activated by activation receptors and tolerant to
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self. Maturation of NK cells include the education of the immature cells to express cell
surface molecules which enable them to interact with the environment such as the killer
cell-immunoglobulin like receptor (KIR) in humans and LY49 in mice. During
development, NK cell inhibitory receptors interact with self-ligands in the bone marrow
stromal cells lead to mount their responsiveness (Figure 3), (Sun et al., 2011; Huntington
et al., 2007).

Figure 3) NK cells education and increased responsiveness, a) increase the NK cells
response with increase the interaction of inhibitory receptors with the MHC class I
self-peptide in the bone marrow stromal cells, b) interaction of activation receptors
with self MHC class I ligands causing cells anergy. Adapted from Sun et al., 2011.

Peripheral NK cell localization and homeostasis
Developing NK cells can leave the site of origin as they are maturing to reside in
the spleen, liver, lung, gut, and other sites where they can be activated and initiate
immune surveillance against tumors and cells infected with pathogens. Factors and
mechanisms by which NK cells traffic between the lymphoid and non-lymphoid organs
5


are still not fully understood. Some chemokines have been identified that regulate the
migration of NK cells between organs. These include CC-chemokine ligands, CCL3,
CCL4, CCL5, CCL19, CXC‑chemokine ligands CXCL12, CXCL16 and CX3CL1, and
some adhesion molecules such as αMβ2 integrin also called macrophage receptor 1;
MAC1 plays a role in controlling of the NK cells trafficking between the different
organs.

Role of cytokines in regulation of NK cells activity
A substantial role for cytokines is well studied in the development and
homeostasis of the lymphoid NK cell lineage, development, maturation, and survival.
Cytokines involved in this process are IL-2, IL-15, IL12 and IL18. NK cells activated by
IL-2 and IL-12 augment tumorlysis function through enhanced perforin binding to the
tumor cell surface (Lehmann et al., 2001). IL-2 is the best known growth factor for NK
cells. It induces NK cells proliferation and augments their cytotoxic function in culture
(Henney et al., 1981; Suzuki et al., 1983). IL- 15 released by macrophages and
monocytes maintains the NK cells survival through its effect on IL-2R, and by enhancing
the expression of the anti- apoptotic factor BCL-2, (Carson et al 1997). Ranson et al.
(2003) assessed the role of the IL-15 on the NK survival. In adoptive transfer assays, NK
cells failed to proliferate in IL-15 deficient mice. In contrast, IL-4, and IL-10 have been
shown to be negative regulators of NK cell responses. NK and T cell secretion of INF-γ
is crucial for innate and adaptive immunity, IL-15 induces NK cells expression of INF-γ
messenger RNA, and IL-18 and IL-21 augment the IL-15 effect on NK cells. IL-15 is the
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main cytokine that activates NK cells to produce IFN-γ through its effect on the STAT
pathway. IL-18 does not exert the same action though it causes a modest increase in the
NK cell expression of IFN-γ upon stimulation; it acts through its effect on NF-κB
activation of the IFN-γ gene promoter (Strengell et al., 2003). IL- 18 is important in
priming NK cells in a subsequent response to IL 12. IL-18, enhances the translation of
IFN-γ mRNA and protein expression (Chaix el al., 2008)
NK cells receptors
NK cell activity is regulated mainly by two types of receptors. Activation
receptors interact with cytokine transducing stimulatory signals to induce cell maturation
and maintain survival. The inhibitory receptors suppress NK cells activity upon their
interaction with the MHC class I, through the intracytoplasmic domain signals called
immunoreceptor tyrosine based inhibitory motifs sequence (ITIM). Recognition of target
cells with down regulation of MHC class I ligands is the function of the some types of the
inhibitory receptors in a process called missing self-phenomenon (Höglund et al., 1997).
Best examples of these receptors are the killer cell Ig-like receptors (KIR) in humans,
Ly49 in the mouse, and CD94/NKG2 in both species. Cells with decreased expression of
MHC class I are susceptible to NK cell killing since the inhibitory signals are suppressed
by failure of MHC class I ligand engagement with the inhibitory receptor. NK cells
deficient in KIR are less competent in target cells killing in contrast to cells expressing
the KIR, (Anfossi, et al., 2006). The proper function of NK cells is controlled by the
balancing signals between the inhibitory and the stimulatory receptor signaling pathways.
Inhibitory receptors signals regulate the specific activation of the NK cells by the
stimulatory receptors, Natural killer receptors (NCR) and CD16 are examples of
7


activation receptors. NKP46, NKP44, and NKP30 are NCRs linked to the type one
intracytoplasmic anchored protein such as CD3-ζ, DAP12 and FcR-γ that contain an
immunoreceptor tyrosine based activation motif (ITAM), (Table 1). NK cell activation is
a result of the synergistic action resulting from a combination of a number of activating
receptors (Bryceson et al., 2005). CD16 is a FcγRIII that binds to FC receptor of IgG
antibodies to induce NK cells antibody-dependent cell-mediated cytotoxicity.
Table 1) Major mouse and human NK cell receptors. Adapted from Jost and Altfeld
2013

Natural killer T cells (NKT)
NKT cells are T lymphocytes that express certain NK surface markers, for
example, NK1.1in the mouse, and CD161 in humans. Their role in immune surveillance
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against different viral infection has been described (Tessmer et al 2009). NKT cells
possess a distinctive T-cell receptor (TCR) and are restricted by CDd1 presentation of
antigen, CD1d restriction develops in the thymus (Bendelac et al., 1997). NK T cells
express unique invariant β chain segments such as Vα14Jα18 TCR in mouse and
Vα24Jα18 in human, this TCR is able to recognize self and foreign lipid molecules. Most
NKT cells also express high levels of CD69 (very early activation marker) and CD44
(Pgp-1), and low levels of CD62L (L-selectin) a phenotype reminiscent of memory T
cells. Different NKT cells subsets have been identified (Table 2), Type I NKT cells are
defined as invariant NKT cells (iNKT), which are the most studied group and is the
characterized with a highly restricted TCR repertoire in human and mouse (Table 1). The
immune response of NKT cells is characterized by their cytotoxic function and their
ability to produce INF-γ and/or IL-4 (Godfrey et al., 2000).
Table 2: Two types of NKT subsets identified in human and mouse and their
different characteristics including the TCR, the CD1d restriction and their
stimulatory ligands, Adapted from: Juno et al., 2012
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NKT cell development
The NKT cells develop in the thymus from the same precursors as conventional
CD4+ and CD8+ T cells, CD4+ CD8+ double-positive cells. In contrast to conventional
T cells, which are selected by MHC–peptide complexes presented by thymic epithelial
cells, iNKT are selected by lipid antigens presented by the non-polymorphic, MHC I-like
molecule CD1d, present on the surface of thymocytes. NKT development in main four
stages, stage 0 (CD24+CD44−NK1.1−) cells, stage 1 (CD24−CD44−NK1.1−), stage 2
(CD24−CD44+NK1.1−) and stage 3 (CD24−CD44+NK1.1+). NKT cells leave the
thymus at stage 2 (Brennan et al., 2013).

NKT cells Ligands
Unlike MHC class I, CD1d presents lipid containing molecules to NKT cells
TCR, rather than peptide fragments. Although natural ligands have yet to be identified,
different studies have investigated the potential molecules that can stimulate NKT
immune response and the initial work revealed the α-galactosylceramide (α-GalCer), as
CDd1 represented NKT cell antigen, and has become the reagent of choice for panactivation of the NKT cell compartment. Subsequent studies demonstrated other
molecules such as the isogloboside 3 (iGb3), as an important endogenous ligand crucial
for NKT cell development and self-recognition in mice and human, (Christiansen et at.,
2008). Although the tissue distribution of NKT cells is well characterized in mouse, it is
less defined in humans and wide range of NKT cell counts known in the human. In the
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mouse, the highest number of NKT cells is present in the thymus, liver and spleen, and
represent 0.5% of total thymus cells and 2.5% of T cells count in spleen and 30% of T
cell count in the liver.

Dendritic cells (DCs)
DCs are a heterogeneous family of immune cells originating from hematopoietic
progenitors in the bone marrow. Their function as antigen presenting cells is well known.
They process endogenous and exogenous peptides and present it on their cell surface
through the MHC class molecule. Immature cells are able to capture and process
pathogens and are less efficient in presenting antigen to T cells (Blanco et al., 2008).
When immature cells encounter pathogen, they recognize it through toll like receptors
(TLR), (Figure 4), they mature and they migrate to the lymph node to present the peptide
antigen to T lymphocytes. Upon pathogen encounter DCs upregulate some surface
molecules such as CD80, CD86, and CD40 that enhance their interaction with the T
lymhocyte. Disturbance of the DCs homeostasis has been linked to many autoimmune
diseases such as diabetes mellitus, multiple sclerosis, systemic lupus erythematosus and
others. DCs produce many cytokines and chemokines that regulate other immune cell
activation and homeostasis; these include type I interferon, IL-12, IL-18, IL10 and IL-23.
DCs are traditionally classified as myeloid DC and lymphoid DCs. Depending on the
surface markers, DCs of uninfected mice showed three subsets of DCs: CD8α+, CD11b+
and LY6G/C+ CD8α+/- (PDCs). PDCs are major cells known to produce IFN α/β in
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response to CMV infection, and have a crucial role in NK cell activation in early CMV
infection.

Figure 4) TLR domains and their adaptor molecules that send signals to the cell
nucleus to produce cytokines, DCs sense MCMV through TLR 9. Adapted from
Takeda and Akira, 2oo4.

III NK cells defense against CMV infection
In response to MCMV infection, NK cells are activated to produce different
cytokines and chemokines such as IFN-γ, macrophage inflammatory proteins (MIP-1α
and MIP-1β), and tumor necrosis factor α (TNFα) during in vivo and in vitro infection.
Early NK cell activation and IFN-γ production during infection of C57BL/6 mice was
due to proinflamatory cytokine nonspecific activation of NK cells during the first two
days of infection. At the late phase of MCMV infection NK cells activated by direct
interaction of the MCMV encoded m157 protein which mimics the MHC class I
12


molecule structure with the lectin-like type II protein (Ly49H) activation receptor
(Dorner et al., 2004).
NK cells kill viral infected cells through pore forming cytolytic protein (perforin)
and interferon γ production that directly inhibits viral replication. Loh et al. (2005)
demonstrated that the primary mechanism of NK cells to control MCMV is to produce
perforin and INF-γ in both the liver and spleen of the infected mice. Loh and his
colleagues showed that NK cells, but not NKT cells, are responsible for the early
protective response to the MCMV infection. In this study, C57BL/6 (B6) NK celldeficient mice lacked NK cells and possessed normal NKT and T cells numbers and
functions,. These mice were infected intraperitoneally with 105 PFU of MCMV and
monitored for survival. A few NK cell-deficient mice (NKD) died on the third day and
80% by the ninth day post infection, compared to wild type B6 mice infected with the
same dose, which survived the infection (figure 5).

Figure 5) Percentage of survival of NKD and B6 mice monitored for 21 days post
MCMV infection. Adapted from Loh et al., 2005
Early control of MCMV infection does not require NKT or T cells, it requires NK
cells. In other experiments, groups of B6 mice were infected with 5x 104 PFU of MCMV.

13


These groups consisted of wild type B6 mice, NKD mice, Rag -/- (lacking mature T and B
cells) and CD1d

-/-

(lacking NK T cells). Viral titers were measured at the 3rd day post

infection in spleen and liver cells. An increase in viral titer occurred in NKD group of
mice compared to the other groups. Rag -/-, CD1d

-/-

deficient mice had comparable viral

titers to the B6 mice (figure 6).

Figure 6) At the 3rd day post infection, NK cells deficient mice showed higher viral
titer in the Liver and spleen comparing to the T, B, and NK T cells deficient mice.
Adapted from Loh et al., 2005.
In this same study, perforin and IFN-γ were found to be crucial for protection from
MCMV induced mortality, and to control the MCMV infection in both the spleen and the
liver. They infected perforin deficient (pfp -/-), IFN-γ deficient (IFN-γ -/-), and B6
(control), mice with different doses of MCMV. Increased lethality occurred in pfp -/- and
IFN-γ -/- mice in comparison to the B6 mice, indicating the importance of the perforin and
IFN-γ in controlling the lethal MCMV infection (figure 7A). Perforin and IFN-γ were
required in both the liver and the spleen to control the MCMV infection (figure 7B and
C). These results contrasted with those of Tay and Welsh (1997) who found that perforin
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was required for controlling MCMV infection of the spleen and IFN-γ was required for
controlling liver MCMV infection.

Figure 7) Perforin and IFN-γ are required for the protection from lethal doses of
MCMV. A) Increased lethality in pfp-/-and IFN-γ-/- mice and increased viral titer in
liver and spleen of pfp-/-mice comparing with B6 mice. C) Increased viral titer in the
liver and spleen of IFN-γ-/- mice compared with B6 mice. Adapted from Loh et al.,
2005.
15


IV- NK cell activation by type I interferon and IL-12 during MCMV
infection.
Type I interferons, discovered by Isaacs and Lindenmann in 1957, binds to their
receptors and activates interferon stimulating gene factor3 which enhances the
transcription of interferon inducible genes through STAT1, STAT2, and STAT4(
Malmgaard el al., 2002; van Boxel-Dezaire et al., 2006) . The biologic effects of Type I
interferons involve the synthesis of essential molecules for cell growth, maintenance of
cell survival, and immune cells activation. In 1996, Orange and Brion, demonstrated that
MCMV infection induces type I interferon and IL12 expression at early times of infection
(Figure 8). These cytokines play a crucial role in NK cells activation and their NK celldependent and independent anti-CMV response is shown in (figure 9). Two groups of
mice, C75B/6 and NK cell/ T cell-deficient (E26) mice, were infected with MCMV and
monitored for the production of IFNα/β, IL12 and IFN-γ. An increase in the production
of these cytokines were seen after 2 days post infection in vivo and in ex vivo using
splenic leukocytes. IFNα/β and IL12 were produced in MCMV infected E26 mice and
C57BL/6 mice. IFN-γ was not induced by infection of the E26 mice (Figure 8). This
result indicated the dependence of IFN- γ production on the presence of NK cells. This
study demonstrated that the early reaction against MCMV is caused by IFNα/β effect and
not by NK cells. Serum levels of IFNα/β and IL12 were higher in the infected E26 mice
than infected immune competent mice. An increase in viral titer was seen in the liver of
E26 mice. Both mice groups were treated with blocking antibodies. About 1 log increase
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in viral load was seen in C57BL/6 compared to untreated group. On the other hand, 1.3
log increased viral load and viral replication in E26 mice treated with the IFNα/β
blocking antibodies. This observation indicated the early production of IFNα/β was
independent of NK or T cells. In contrast, IL-12 neutralization significantly increased the
viral load in E26 infected mice at 3rd day post infection. About 2 log increase in viral
burden was observed in NK cell deficient mice (Table III), this observation showed that
IFNα/β, and IL-12 produced early during infection in the presence of NK cells have a
significant antiviral effect.

Figure 8) Early production of IFNα/B, IL-12 p40, and IFN-γ at the day 2 after
MCMV infection of C57BL/6 or E26 mice in serum and in splenic leukocytes.
Adapted from. Orange and Biron. 1996
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Figure 9) IL-12 role in control of MCMV induced hepatic necrosis is independent on
NK cells. Adapted from Orange and Biron, 1996.

Table III) Role of IFNαβ and IL-12 in control of viral burden in E26 and C57BL/6
mice. Cytokine neutralizing anti bodies were used to detect NK independent
response. Adapted from Orange and Biron 1996.
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In the same study, Orange and Brion (1996) assessed the role of IFNα/β in
regulating NK cell cytotoxicity and NK cell proliferation during MCMV infection. They
evaluated splenic and bone marrow NK cell mediated cytotoxic function against

51

Cr-

labeled YAC-1 target cells in MCMV infected C57BL/6 mice treated with IFNα/β
neutralizing antibodies. IFNα/β neutralization caused significant reduction in NK cell
cytotoxicity of the spleen and bone marrow cells. There was about 75% less NK cell
cytotoxic activity observed in mice treated with anti IFNα/β (Figure 10 A). The frequency
and percentage of blast NK cells (NK1.1+ CD3-) were assessed by flow cytometry.
Significant reduction in NK cell proliferation and blast formation was observed in
C57BL/6 infected mice treated with IFNα/β neutralizing antibodies compared with untreated mice (Figure 10 B).

Figure 10) The crucial role of IFNα/β in induction of NK cell proliferation and
cytotoxic activity during MCMV infection. A) Splenic and bone marrow NK cell
cytotoxic activity inhibited by IFNα/β neutralization. B) Percentage and frequency
of blast NK1.1+ CD3- cell significantly reduced by IFNα/β neutralization. Adapted
from Orange and Biron. 1996.
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Type I interferon activate NK cells during MCMV infection through STAT
mediated pathway.
Nugynus el al. (2002) studied the mechanism of INFα/β and IL-12 regulation of
NK cells function during MCMV infection and the mediators required for this regulation.
They assessed the role of type I interferon mediated NK cell cytotoxicity and
proliferation. This study showed for the first time that INFα/β mediates NK cell
proliferation through the STAT mediated pathway in vivo. They demonstrated in MCMV
infected C57BL/6 mice that the NK cell expansion is through the IL-15/ STAT mediated
pathway and not through the direct effect of IFNα/β on NK cells. Within the first 2 days
of CMV infection, NK cell proliferation and cytotoxic activity were enhanced by type I
interferon and INF γ produced in response to IL-12.Nuguyen et al. (2002) demonstrated
that NK cell proliferation starts as early as 1.5 day post MCMV infection where about
25% of NK cells were proliferated, 60% of them perform cytotoxic activity through
perforin secretion, 30-60% secreted INF-γ, all IFN-γ secreted cells was able to produce
perforin, and 20% of NK cells perform all of the three activities(Figure 11). This
observation indicated that NK cells can exert more than one antiviral response during
MCMV infection. Genetic mutation of INFα/β receptor blocked the NK cell response to
INFα/β action and reduced cytotoxicity but the production of INF-γ was not affected.
Cytotoxic function mediated by STAT1 activation. STAT1 knockout mice from C57BL/6
background showed reduced NK cell cytotoxic activity (Figure 12). STAT1- mice NK
cells showed higher viral content than the STAT4- mice. On the other hand STAT4 - mice
showed decreased number of IFN-γ producing NK cells. IFN-γ serum level decreased in
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STAT4- mice and surprisingly, serum IFN-γ levels were higher in STAT1 - than STAT4infected mice (Nguyen et al., 2002). This observation was attributed to the compensatory
production of IL-12 in mice with impaired NK cell cytotoxic function. NK cell
proliferation in response to the infection was detected by BrdU incorporation of the cells
in vivo. Numbers of BrdU+ cells were markedly reduced in IFNα/βR- mice but not in IL12 deficient ones (IL-12P35-) (figure 13).
IL-15 is important in NK cell survival and homeostasis (Ranson et al., 2003), IL15 production is enhanced by IFNα/β, during CMV infection through the STAT1
mediated pathway (Nguyen et al., 2002). MCMV infected IFNα/βR- mice showed
decrease level of IL-15 and STAT- mice showed impaired IL-15 production (figure 14).

Figure 11) MCMV induced perforin, IFN-γ, and NK cell proliferation at day 1.5
post i.p infection. Adapted from Nguyen et al., 2002

21


Figure 12) NK cell cytotoxicity requires STAT1 mediated signaling. Adapted from
Nguyen et al., 2002.

Figure 13) NK cell proliferation indicated by BrdU+ NK cell numbers and
frequency, were markedly decreased in IFN α/βR- and STAT1- MCMV infected
mice. Adapted from Nguyen et al., 2002.
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Figure 14) STAT1 and IFNα/β receptor are essential for IL-15 mRNA expression.
IL-15 production in MCMV infected mice and mice treated with recombinant IFNα require STAT1 signaling. Adapted from Nguyen et al., 2002.

V- NK cell activation by NK T cell stimulation during CMV infection.
Although the role of NK T cells in innate immune surveillance against tumors is
well studied, the antiviral response and the immune regulation for NK T antiviral
function is less well understood. Various studies used α galactocylceramis (α-GalCer) as
NKT cell external stimulators to activate NK T cell immune response in vivo (Kitamura
et al., 2000). α-GalCer is a glycolipid molecule presented by CD1d to the invariant TCR
of the NK T cells. After NK T cell stimulation with the α-GalCer, a rapid release of IFNγ occurd. Carnaud and his colleagues, (1999), used the α-GalCer to study the functional
link between NK T and NK cells. This study showed that NK cells activated by IFN-γ
that produced by α-GalCer stimulated NK T cells. IFN-γ is produced as early as 90
minutes after α GalCer injection in immunocompetent mice and continues up 6 hours
post α-GalCer injection. This first peak of IFN-γ is resulted from activation of NK (CD3-
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NK1.1+) cells, (figure 15). In this study immunocompetent (C57BL/6), T, B, and NK T
cell deficient (RAG -/-), and selective NK T deficient (CD1d -/-) mice were injected by αGalCer and monitored for IFN-γ production. IFN γ was not produced by NK cells in
RAG-/- and in CD1d-/- mice, indicating that activation of NK cells to produce IFN-γ is a
secondary event to NK T cell activation (Figure 15).

Figure 15) α-GalCer induce rapid NK cells activation and IFN-γ production in
C57BL/6 (B6) mice but not in RAG -/- (B), and CD1d-/- mice (C). NK cell activation
require CD1d/NK T cells pathway (C). Adapted from Carnaud et al., 1999.
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Dommelen el al. (2003) tested the effect of α-GalCer activated NKT cells on NK
cell activation during MCMV infection in visceral organs. In this study, they detected an
inhibition of the viral replication in MCMV infected and α-GalCer treated C57BL/6 mice
at day two, and four post intraperitoneal (i.p) infection compared to infected untreated
mice, They found viral replication in NKT cell deficient mice equal to the wild type
mice treated with α-GalaCer, and concluded that the antiviral effect of NKT cells was
not a result of direct NKT cell involvement in viral clearance, but rather a result from
transactivation of NK cells by IFN-γ production. NKT deficient mice (B6.Jα281-/-),
(Figure 16) showed equal viral titer to the control immune competent mice (C57BL/6)
infected with MCMV and treated with a GalCer. The NKT cell antiviral effect in
response to α GalaCer is a result of their production of IFN-γ which enhances more IFN-γ
production from NK cells and promotes their perforin mediated toxicity. In mice
deficient in perforin and IFN-γ, αGalaCer did not induce significant decrease in viral titer
(Figure 16).

Figure 16) MCMV replication in C57BL/6 and NKT cell deficient (Jα281-/-) mice
liver and spleen. At day 2,4, and 6, viral replication in NKT deficient mice is
equivalent to that in control mice. Adapted from Dommelen et al., 2003.
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NKT cell activation during MCMV infection and cytokines requirment for this
activation still under continues study. Tyznik et al. (2008) hypothesized that iNKT cell
activation during MCMV infection was induced by IL-12 secretion from DCs. The iNKT
cell response to MCMV infection in mouse is independent to antigen presentation
through CD1d / TCR interaction. The mechanism of activation of iNKT cells by DCs
during MCMV was studied in cell culture and in vivo as well. Mouse bone marrow
derived DCs were infected by MCMV and cocultured with splenic iNKT cells. iNKT cell
IFN-γ production was induced but not IL-4 in contrast to iNKT cocultured with mock
infected DCs where no IFN-γ was detected (Figure 17A). Furthermore, they postulated
that the iNKT activation is dependent on TLR9 activated DCs, while DC derived from
TLR9 mutated mice failed to stimulate iNKT cells IFN-γ production. In addition, iNKT
stimulated by DC derived from mice lacking the IL-12p40 (IL-12p40-/-), and CD1d
(CD1d -/-) exhibited decreased the iNKT cell induced IFN-γ production. CD1d -/- DCs
induced iNK T cells IFN-γ production was similar to that produced with wild type DCs
coculture, and CD1d blocking antibodies showed no effect on the IFN-γ production in
iNK T/ DCs culture. Collectively these results indicated that DCs recognize MCMV virus
through TLR9 and produce IL-12. IL-12 activates IFN-γ production by iNKT cells
independently on CD1d/TCR antigen presentation (Figure 17 B).
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Figure 17) A) IFN-γ production by iNKT cells when cocultured with wild type
MCMV infected and Mock non infected DCs, B) IFN-γ production by iNKT cells
cocultured with MCMV infected and Mock non infected DCs generated from
TLR9,IL-12, IL-18, and CD1d deficient mice, and wild type and CD1d defecient
mice treated with CD1d blocking antibodies. Adapted from Tyznik et al., 2008

In vivo, iNKT cell activation has been detected in MCMV infected C75BL/6 mice
by analyzing α-GalCer/CD1d tetramer+ iNKT. Early activation markers, CD25 and
CD96 were up regulated to be detected at 12 to 36 h post infection in the liver and spleen
(figure 18 A, B) and intracellular level of IFN-γ was detected ex vivo from liver and
spleen at 36 hours post infection. The result is similar to those of the in vitro study.
MCMV infection in vivo induces early iNKT cells activation and IFN-γ production but
not IL4 or TNF production (Tyznik et al., 2008).
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Figure 18 A) iNKT cell activation at the early phase of MCMV infection detected by
expression of CD25 iNKT cells in the liver and spleen of the MCMV infected mice
(open histogram) compared with the control uninfected mice injected with buffer
saline (shaded histogram). B) Time course of CD25 expression in liver and spleen of
MCMV infected mice. Adapted from Tyznik et al., 2008.

Wesley et al., 2008, studied in C57BL/6 mouse the Vα14iNKT cells response to
MCMV infection. They demonstrated that Vα14iNKT cells were activated to produce
IFN-γ cytokine. In contrast to NK cells, Vα14iNK T cells did not proliferate during
MCMV infection. C57BL/6 mice were infected by MCMV virus for 20 to 40 hours and
the cells were analyzed for signs of activation and INF-γ production. Vα14iNKT
decreased in number over time, in MCMV-infected mice compared with uninfected mice
(Figure 19A). Although the iNKT cells did not proliferate in response to MCMV
infection, they were rapidly activated and the expression of CD25+ cells on the surface of
the Vα14iNKT cells was detected at 20 hrs post MCMV infection (figure 19B,C) similar
to the observation of Tyzanic and colleagues (2008).
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Figure19 A) Va14i NK T cells are activated but do not proliferate in response to
MCMV infection in vivo, number of Va14iNKT are less at 40 hrs than at 20 hrs
post infection. Adapted from Wesley et al., 2008

Figure 19 B, C) Increased iNKT cell activation indicated by increase in CD25
expression, the highest level at 20 hrs post infection of C57BL/6 mice. Adapted from
Wesley et al., 2008

Figure 19D) percentage, and total iNKT and NK cell numbers detected in cells from
C57BL/6 mice liver, decreasing the number and percentage of iNKT after 1.5 day
post infection, and an increase of NK cells number and percentage first 4 days post
infection. Adapted from Wesley et al., 2008.
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Wesley et al. (2008) demonstrated that iNKT cells enhanced NK cell activation
and IFN-γ production at 30 hours post infection of C57BL/6 mice. The percentages of
IFN-γ +NK and IFN-γ +NKT cells was measured and the result showed comparable
numbers of both IFN-γ+ producing cells in the infected liver, while NK cells are the
predominant IFN-γ producer in the spleen. IFN-γ and other inflammatory cytokines were
significantly reduced in NK T cells deficient mice (CD1d-/-) spleen compared with CD1d/+

(figure 20), In conclusion, these observations suggests that Vα14iNKT cells are

activated but did not proliferate in response to MCMV infection, and activated iNKT
cells secrete IFN-γ that amplify the IFN-γ production by NK cells, and other innate
cytokine production.
A

B

Figure 20) NK cell activation (A) and innate cytokines production (B) are
significantly decreased in NKT cells deficient mice. Adapted from Wesley et al.,
2008
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VI- Plasmacytoid dendritic cells activates NK cells during CMV
infection
Plasmacytoid dendritic cells (PDC) are a dendritic cell subtype that recognize
DNA and RNA viral antigen through the Toll like receptor 7 (TLR7) and TLR9 which
promotes Type I interferon secretion through MyD88-IRF7 signaling pathway. During
MCMV infection, PDCs and their produced cytokines interact with NK cells leads to
their activation and cytokine secretion. The only well-known antiviral response of the
PDC is through the production of Type I interferons that regulate other immune cells
such as NK cells and other DCs subtypes to shape the innate immune response (Dalod et
al., 2003).
Swiecki et al. (2010) studied the crucial role of PDCs in NK cells antiviral
activity against MCMV. They used a new approach by using transgenic mice on
C57BL/6 background that express diphtheria toxin receptor, these mice selectively
depleted of PDCs with the diphtheria toxin (DT) treatment. Such mice were infected with
MCMV intraperitoneally. In contrast to control immune competent mice, DT-treated
mice exhibited increased viral replication in the liver and the spleen during early
infection and in the salivary gland at day eight post infection. NK cell immune response
to MCMV includes two phases; the early phase develops by a nonspecific activation of
NK cells by the innate cytokines and independent on LY49H receptor interaction. The
late phase of NK cell immune surveillance involves expansion of LY49H+ NK cells that
activated by the direct interaction of the LY49H receptor with the MCMV protein
(m157). To assess the effect of PDC depletion on the nonspecific (early) phase of NK cell
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activation and IFN-γ production and to exclude the NK cell activation through the direct
interaction of LY49H with mcmv protein (m157), they used MCMV virus lacking m157
protein. The effect of PCDs depletion on NK cells activation was apparent since the early
hours of infection. Reduced number of activated NK cells (CD96+) (figure 21), and
impaired NK cell cytotoxic activity were observed in PDC depleted mice compared with
wild type, (figure 22). The percentage of IFN-γ producing NK cells was increased at later
times post infection of the DT treated mice. There was no effect observed on the NK cells
selective activation, where the number of LY49H+ NK cells increased in later time during
infection of PDC depleted mice and more IFN-γ was produced than in control mice
(figure 23, A and B).

Figure 21) Decrease in activated NK cells number of DT-treated mice at the early
time post MCMV infection. Adapted from Swiecki et al., 2010
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Figure 22) NK cells cytotoxicity during different time points of MCMV infection to
the DT treated and control mice. Adapted from Swiecki et al., 2010

Figure 23 A) IFN γ production in DT-treated and control MCMV infected mice. B)
Effect of PDC depleation on specific and nonspecific NK cell activation, indicated by
NK 1.1+ and Ly49H+ NK cells respectively. Adapted from Swiecki et al., 2010.

VII- Conclusion and future studies
Collectively, the data presented in this study illustrate the innate immune response
exerted by NK cells and other innate immune cells to destroy MCMV-infected cells. NK
cells are activated either directly by interaction of activation receptors with viral encoded
proteins, or indirectly through the effect of the proinflamatory cytokines. The m157 viral
protein interacts with Ly49H receptor to initiate specific activation of NK cells in
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C57BL/6 mice. Nonspecific activation of NK cells through the action of Type I interferon
occurs at an early time during infection. The early response to MCMV infection is Type I
interferon production by infected DCs subsets. PDCs recognize MCMV virus through
TLR9 and produce IFNα/β, IL-12, and other cytokines. IFNα/β promoting cytotoxic
activity by perforin release, inducing NK cell proliferation and maintaining NK cell
survival through STAT1/IL-15 pathway. IL-12 is also produced by DCs during MCMV
infection. IL-12 induces NK cells as well as NKT cell activation and IFN-γ production.
Although NK cell proliferation is detected during MCMV infection, NKT cells do not
expand in infected mice. One of the lethal sequelae of MCMV infection is the
neurological complications such as, hearing loss and visual impairment. Most of the
studies assessed the innate immune response in visceral organs, and the immune response
against neuronal MCMV infection needs to be evaluated.
In future studies, factors involved in NK cell activation during MCMV infection
of neurons need to be identified. NK cell activation by IFNα/β in MCMV neuronal
infection can be studied by assessing the NK cell-mediated cytolysis of YAC-1 target
cells in MCMV-infected mice. Compared to MCMV-infected mice infected
intracerebrally, MCMV-infected mice treated with IFNα/β blocking antibodies should
show increased neurological deficits, increased viral titers, and decreased NK cell
cytolysis. The requirement of type I interferons in inducing NK cell proliferation can be
assessed by detecting NK1.1+ CD3- cells by flow cytometer in infected brain tissue.
Future evaluation of the role of NKT cells in activating NK cells in MCMV-infected
neuronal tissue will provide a better understanding of the innate antiviral immune
surveillance. IFN-γ production in brain tissue (ex vivo) in C57BL/6 (control), and NKT
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cell-deficient (CD1d -/-) C57BL/6 mice should indicate NKT cell involvement in immune
surveillance against neuronal MCMV infection in the control but not CD1d-deficient
C57Bl/6 mice.
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